rs190979363

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003235.5(TG):​c.7755-9T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00519 in 1,611,926 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0045 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 28 hom. )

Consequence

TG
NM_003235.5 intron

Scores

2
Splicing: ADA: 0.003053
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.850

Publications

0 publications found
Variant links:
Genes affected
TG (HGNC:11764): (thyroglobulin) Thyroglobulin (Tg) is a glycoprotein homodimer produced predominantly by the thryroid gland. It acts as a substrate for the synthesis of thyroxine and triiodothyronine as well as the storage of the inactive forms of thyroid hormone and iodine. Thyroglobulin is secreted from the endoplasmic reticulum to its site of iodination, and subsequent thyroxine biosynthesis, in the follicular lumen. Mutations in this gene cause thyroid dyshormonogenesis, manifested as goiter, and are associated with moderate to severe congenital hypothyroidism. Polymorphisms in this gene are associated with susceptibility to autoimmune thyroid diseases (AITD) such as Graves disease and Hashimoto thryoiditis. [provided by RefSeq, Nov 2009]
TG Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thyroid cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 8-133116600-T-G is Benign according to our data. Variant chr8-133116600-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 376938.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0045 (685/152346) while in subpopulation NFE AF = 0.00662 (450/68016). AF 95% confidence interval is 0.00611. There are 2 homozygotes in GnomAd4. There are 349 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGNM_003235.5 linkc.7755-9T>G intron_variant Intron 44 of 47 ENST00000220616.9 NP_003226.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGENST00000220616.9 linkc.7755-9T>G intron_variant Intron 44 of 47 1 NM_003235.5 ENSP00000220616.4

Frequencies

GnomAD3 genomes
AF:
0.00450
AC:
685
AN:
152230
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000916
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00662
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00450
AC:
1132
AN:
251476
AF XY:
0.00447
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.00327
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0140
Gnomad NFE exome
AF:
0.00631
Gnomad OTH exome
AF:
0.00472
GnomAD4 exome
AF:
0.00526
AC:
7679
AN:
1459580
Hom.:
28
Cov.:
30
AF XY:
0.00516
AC XY:
3750
AN XY:
726254
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33440
American (AMR)
AF:
0.00121
AC:
54
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00402
AC:
105
AN:
26120
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39682
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86220
European-Finnish (FIN)
AF:
0.0127
AC:
677
AN:
53410
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5758
European-Non Finnish (NFE)
AF:
0.00590
AC:
6548
AN:
1109922
Other (OTH)
AF:
0.00415
AC:
250
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
384
767
1151
1534
1918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00450
AC:
685
AN:
152346
Hom.:
2
Cov.:
33
AF XY:
0.00468
AC XY:
349
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41588
American (AMR)
AF:
0.00144
AC:
22
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.0141
AC:
150
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00662
AC:
450
AN:
68016
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00550
Hom.:
1
Bravo
AF:
0.00331
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00616
EpiControl
AF:
0.00622

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Nov 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Iodotyrosyl coupling defect Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
8.4
DANN
Benign
0.51
PhyloP100
0.85
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0031
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190979363; hg19: chr8-134128844; API